Enavate Sciences GP, LLC Long-Term Concentrated

CIK: 0001953107 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 17, 2026

Total Value ($000): $506,782 (100.0% shares, 0.0% debt)

Holdings (7)

Increased Positions (1)

ZBIO ZENAS BIOPHARMA INC 28.1%

Value ($000) $142,305 (+70.4%) Shares 3,919,159 (+4.2%) Est. Cost $16.29 Unrealized +101.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ZBIO	ZENAS BIOPHARMA INC	3,919,159 (+4.2%)	$142,305 (+70.4%)	28.1%	$16.29	+101.8%	COM	98937L105

Decreased Positions (1)

CAMP CAMP4 THERAPEUTICS CORP 3.7%

Value ($000) $18,610 (+63.9%) Shares 3,035,825 (-19.8%) Est. Cost $8.22 Unrealized -48.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CAMP	CAMP4 THERAPEUTICS CORP	3,035,825 (-19.8%)	$18,610 (+63.9%)	3.7%	$8.22	-48.2%	COM	13463J101

Unchanged Positions (5)

IMNM IMMUNOME INC 20.2%

Value ($000) $102,429 Shares 4,768,583 Est. Cost $11.41 Unrealized +53.8%

SION SIONNA THERAPEUTICS INC 20.1%

Value ($000) $101,946 Shares 2,478,030 Est. Cost $16.34 Unrealized +132.1%

UPB UPSTREAM BIO INC 13.2%

Value ($000) $66,781 Shares 2,459,703 Est. Cost $22.33 Unrealized +11.5%

CMPX COMPASS THERAPEUTICS INC 8.3%

Value ($000) $41,822 Shares 7,788,150 Est. Cost $1.66 Unrealized +178.1%

BBOT BRIDGEBIO ONCOLOGY THERAPEUT 6.5%

Value ($000) $32,889 Shares 2,626,946 Est. Cost $11.58 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
IMNM	IMMUNOME INC	4,768,583	$102,429	20.2%	$11.41	+53.8%	COM	45257U108
SION	SIONNA THERAPEUTICS INC	2,478,030	$101,946	20.1%	$16.34	+132.1%	COM	829401108
UPB	UPSTREAM BIO INC	2,459,703	$66,781	13.2%	$22.33	+11.5%	COM	91678A107
CMPX	COMPASS THERAPEUTICS INC	7,788,150	$41,822	8.3%	$1.66	+178.1%	COM	20454B104
BBOT	BRIDGEBIO ONCOLOGY THERAPEUT	2,626,946	$32,889	6.5%	$11.58	—	COM NEW	107924102